Skip to main content
Michael Mannstadt, MD, Endocrinology, Boston, MA, Massachusetts General Hospital

MichaelMannstadtMD

Endocrinology Boston, MA

Osteoporosis & Bone Metabolism Medicine, Parathyroid

Chief, Endocrine Unit, Massachusetts General Hospital Associate Professor of Medicine, Harvard Medical School

Dr. Mannstadt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mannstadt's full profile

Already have an account?

  • Office

    55 Fruit St
    Wang Acc 730a Endocrine Associates
    Boston, MA 02114
    Phone+1 617-726-8720
    Fax+1 617-726-7543
  • Is this information wrong?

Summary

  • I am a board certified endocrinologist specializing on diseases of bone and mineral metabolism. My clinical interests include hypoparathyroidism, hyperparathyroidism, hypocalcemia, hypercalcemia, hyperphosphatemia, hypophosphatemia, genetic bone diseases, Fibrous dysplasia, McCune-Albright syndrome and osteoporosis.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2007
  • Massachusetts General Hospital
    Massachusetts General HospitalChief Residency, Internal Medicine, 2005 - 2006
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
  • Friedrich-Schiller-Universität Jena
    Friedrich-Schiller-Universität JenaClass of 1991

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2003 - 2026
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A New Multi-System Disorder Caused by the Gαs Mutation p.F376V  
    Michael Mannstadt, MD, The Journal of Clinical Endocrinology and Metabolism

Lectures

  • Challenges in Treating Hypoparathyroid Patients (Repeat) 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Challenges in Treating Hypoparathyroid Patients 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 Inhibitor 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Join now to see all

Press Mentions

  • Recall of Takeda's Natpara Leaves Patients in Health Limbo
    Recall of Takeda's Natpara Leaves Patients in Health LimboSeptember 16th, 2019
  • Understanding Healthy Bone Growth in Childhood to Improve Long-Term Quality of Life
    Understanding Healthy Bone Growth in Childhood to Improve Long-Term Quality of LifeApril 29th, 2014
  • Hormone Level May Reflect Mortality Risk Among Dialysis Patients
    Hormone Level May Reflect Mortality Risk Among Dialysis PatientsAugust 6th, 2008
  • Join now to see all

Grant Support

  • R01NIH NIDDKPresent

Professional Memberships

Hospital Affiliations